Clinically, increased levels of FSH and LH in women of reproductive age were suggested to be indicative of ovarian dysgenesis, which included primary amenorrhea, ovarian insufficiency, and other disorders (Qiu et al., 2022). Here, BRD2 is linked to ovarian dysfunction.